Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer02:18

Cancer

53.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variants of the transporter SLC22A4 affect the abundance and survival of <i>Fusobacterium nucleatum</i> in colorectal cancer.

Gut microbes·2026
Same author

Oncometabolite signatures from tumor-stroma crosstalk as potential non-invasive biomarkers.

Cell death discovery·2026
Same author

Brain-Targeted Delivery of Phenformin Using Phospholipid and Non-Phospholipid Vesicles for SHH Medulloblastoma.

Nanomaterials (Basel, Switzerland)·2026
Same author

Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides.

Disease models & mechanisms·2026
Same author

Nanohybridization as a Route to a Water-Friendly Therapeutic Tool for Rescuing Misfolded Proteins.

ACS nanoscience Au·2026
Same author

AMBRA1 enhances Sonic Hedgehog signaling during cerebellar development and in medulloblastoma.

Developmental cell·2026

Related Experiment Video

Updated: Dec 21, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K

Nanotechnology-Based Strategies to Develop New Anticancer Therapies.

Massimiliano Magro1, Andrea Venerando1, Alberto Macone2

  • 1Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, 35020 Legnaro (PD), Italy.

Biomolecules
|May 14, 2020
PubMed
Summary

Nanotechnology offers novel strategies for cancer treatment by utilizing nanomaterials as drug delivery vehicles. These advanced materials enhance drug efficacy and enable the development of multifunctional theranostic tools for improved cancer management.

Keywords:
amino oxidasesbiomoleculescancerhyperthermiananoparticlespolyamines

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

675
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.2K

Related Experiment Videos

Last Updated: Dec 21, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

675
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.2K

Area of Science:

  • Oncology
  • Materials Science
  • Biotechnology

Background:

  • Conventional cancer therapies face limitations in efficacy and side effects.
  • Nanotechnology presents a promising frontier for overcoming these therapeutic challenges.
  • Diverse nanomaterials offer unique properties for advanced cancer management.

Purpose of the Study:

  • To summarize current nanotechnological applications in cancer management.
  • To explore nanomaterials, surface functionalization, and drug ligands for cancer therapy.
  • To highlight the potential of nanomaterials in developing theranostic tools.

Main Methods:

  • Review of current literature on nanotechnology in cancer.
  • Analysis of nanomaterial properties and their functionalization techniques.
  • Examination of drug delivery systems utilizing nanoparticles.

Main Results:

  • Nanomaterials serve as effective drug delivery vehicles, enhancing drug loading, half-life, and bioavailability.
  • Intrinsic properties of nanomaterials (e.g., fluorescence, optical, magnetic) enable multifunctional theranostic tools.
  • Enzyme-conjugated nanoparticles show potential for smart anticancer devices.

Conclusions:

  • Nanotechnology provides a versatile platform for innovative cancer treatment strategies.
  • Combining drug properties with nanomaterial carriers leads to advanced theranostic capabilities.
  • Further research into nanotechnology holds significant promise for addressing human cancer threats.